# TAVNEOS

NDC: 73556-168
Generic name: avacopan
Labeler / Manufacturer: ChemoCentryx, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20211018

FDA application: NDA214487

## Active ingredients

- AVACOPAN: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73556-168"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73556-168
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c93cbc0b-29a3-46a5-9c85-41815ea5cf4a